We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
In the wake of the 2014 Ebola outbreak, the FDA is weighing the best options for testing and rapidly deploying treatments for emerging infectious diseases and wants to hear from you on the subject. Read More
Celgene, Natco Settle Revlimid Patent Spat
Turing to Cut Jobs, Seek New CEO in Shake-Up
DEA Relaxes Controls on Approved Cannabidiol Trials
Judge Dismisses NYU Cancer Drug Royalties Claim Against Pfizer
Adamas Compound Hits Primary Endpoint in Study
Kamada’s Rabies Candidate Meets Goal Read More
A California supplement maker is in hot water after being accused of making drug-like claims about its products and relying on improper production methods. Read More
A growing number of health insurers are asking pharmaceutical manufacturers to tie payment to how a drug performs. Some drugmakers are taking the leap into this relatively unchartered territory. Read More
With an eye toward improving product quality, the FDA is inviting drugmakers to join a program to evaluate emerging manufacturing technology. Read More
The FDA is asking Sun Pharmaceuticals to conduct tests and turn over reams of paperwork in response to a warning letter alleging more than a dozen cGMP violations. Read More
The FDA has issued a proposed rule harmonizing regulations for prescription and OTC fixed dose combination products, along with co-packaged drugs and combinations of active ingredients under consideration for inclusion in an OTC monograph. Read More
Pfizer’s Pristiq Falls Short in Pediatric Study
FDA Alerts Compounders on Contamination Following Explosions at Chinese Warehouse
Actelion’s Uptravi Scheduled for January Launch
CMS Launches Online Drug Spending Dashboard
EC to Revisit Pharma Fee System Next Year
pSivida’s Eye Formula Medidur Shines in Phase 3 Trial
Merck KGaA, Pfizer Advance Phase 3 Trials of Ovarian and Bladder Cancer Candidate
AZ Snatches FDA Approval for Zurampic Read More
In observance of the holiday season, Drug Industry Daily will not be published Thursday, Dec. 24 and Friday, Dec. 25. The next issue will be published Monday, Dec. 28. Read More